Robotic radiotherapy for prostate cancer with CyberKnife™;Radiothérapie robotisée des cancers de prostate par CyberKnife™

Cancer/Radiotherapie

Volumn 11, Issue 8, 2007, Pages 476-482

  Hannoun Levi, J M ^a   Benezery, K ^a   Bondiau, P Y ^a   Chamorey, E ^a   Marcie S ^a   Gerard, J P ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

CyberKnife ; Image guided radiation therapy; Prostate cancer; Radiosurgery

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; ROBOTICS; SHORT SURVEY; TREATMENT OUTCOME;

EQUIPMENT DESIGN; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RISK FACTORS; ROBOTICS;

EID: 36849070994     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2007.07.005     Document Type: Short Survey

References (32)

1. Beckendorf V., Guerif S., Le Prise E., Cosset J.M., Lefloch O., Chauvet B., et al. The GETUG 70 vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 1056-1065
2. Bey P., Carrie C., Beckendorf V., Ginestet C., Aletti P., Madelis G., et al. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 513-517
3. Chang S.D., Main W., Martin D.P., Gibbs I.C., and Heilbrun M.P. An analysis of the accuracy of the CyberKnife™: a robotic frameless stereotactic radiosurgical system. Neurosurgery 52 (2003) 140-146
4. Cosset J.M., and Haie-Meder C. Brachytherapy for prostate cancer: high dose rate or low-dose rate?. Cancer Radiother. 9 (2005) 610-619
5. Dearnaley D.P., Khoo V.S., Norman A.R., Meyer L., Nahum A., Tait D., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
6. Dearnaley D.P., Hall E., Lawrence D., Huddart R.A., Eeles R., Nutting C.M., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br. J. Cancer 92 (2005) 488-498
7. Demanes D.J., Rodriguez R.R., Schour L., Brandt D., and Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1306-1316
8. Eulau S.M., Van Hollebeke L., Cavanagh W., et al. High dose rate Iridium 192 brachytherapy in localized prostate cancer: Results and toxicity with maximum follow-up of 10 years. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 149
9. Fowler J.F., Ritter M.A., Chappell R.J., and Brenner D.J. What hypofractionated protocols should be tested for prostate cancer?. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 1093-1104
10. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol. 44 (2005) 265-276
11. Galalae R.M., Martinez A., Mate T., Mitchell C., Edmundson G., Nuernberg N., et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without néoadjuvante androgen suppression for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 1048-1055
12. Galalae R.M., Martinez A., Nuernberg N., Edmundson G., Gustafson G., Gonzalez J., et al. Hypofractionated conformal HDR brachytherapy in hormone naive men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?. Strahlenther. Onkol. 182 (2006) 135-141
13. Gibbs I.C. Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife™ robotic system. Cancer Radiother. 10 (2006) 283-287
14. Herrmann T.R., Rabenalt R., Stolzenburg J.U., Liatsikos E.N., Imkamp F., Tezval H., et al. Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter?. World J. Urol. 25 (2007) 149-160
15. Hu J.C., Nelson R.A., Wilson T.G., Kawachi M.H., Ramin S.A., Lau C., et al. Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy. J. Urol. 175 (2006) 541-546
16. King C.R., Lehmann J., Adler J.R., and Hai J. CyberKnife™ radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol. Cancer Res. Treat. 2 (2003) 25-30
17. Kupelian P.A., Thakkar V.V., Khuntia D., Reddy C.A., Klein E.A., and Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 1463-1468
18. Lefkopoulos D., and Mazeron J.J. Presentation of a special cancer radiotherapy volume on the latest developments and clinical applications of image-guided radiotherapy (IGRT) and adaptive radiotherapy (ART)]. Cancer Radiother. 10 (2006) 219-221
19. Martinez A.A., Pataki I., Edmundson G., Sebastian E., Brabbins D., and Gustafson G. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 61-69
20. Martinez A.A., Gustafson G., Gonzalez J., Armour E., Mitchell C., Edmundson G., et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome inunfavorable prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 316-327
21. Madsen B.L., Hsi R.A., Pham H.T., Presser J., Esagui L., Corman J., et al. Intrafractional stability of the prostate using a stereotactic radiotherapy technique. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 1285-1291
22. Madsen B.L., Hsi R.A., Pham H.T., Fowler J.F., Esagui L., and Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 1099-1105
23. Pickles T., Kim-Sing C., Morris W.J., Tyldesley S., and Paltiel C. Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 11-18
24. Pisansky T.M. External-beam radiotherapy for localized prostate cancer. N. Engl. J. Med. 355 (2006) 1583-1591
25. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1097-1105
26. Pollack A., Hanlon A.L., Horwitz E.M., Feigenberg S.J., Konski A.A., Movsas B., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 518-526
27. Rodriguez R.R., Demanes D.J., and Altieri G.A. High-dose-rate (HDR) monotherapy for early stage prostate cancer: Preliminary results. Brachytherapy 2 (2003) 62 [Abstract]
28. Smith Jr. J.A., and Herrell S.D. Robotic-assisted laparoscopic prostatectomy: do minimally invasive approaches offer significant advantages?. J. Clin. Oncol. 23 (2005) 8170-8175
29. Thames H., Kuban D., Levy L., Horwitz E.M., Kupelian P., Martinez A., et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 929-943
30. Yu C., Main W., Taylor D., Kuduvalli G., Apuzzo M.L., and Adler Jr. J.R. An anthropomorphic phantom study of the accuracy of Cyberknife™ spinal radiosurgery. Neurosurgery 55 (2004) 1138-1149
31. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1111-1116
32. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi Jr. C.J., Miller D.W., Adams J.A., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239